Variant report
Variant | nsv947622 |
---|---|
Chromosome Location | chr10:56360404-56368476 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:16)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 2)
- miRNA target sites (count:0)
(count:16 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr10:56365480-56365630 | GM12864 | blood: | n/a | n/a |
2 | EBF1 | chr10:56367734-56368066 | GM12878 | blood: | n/a | chr10:56367900-56367913 chr10:56367901-56367912 chr10:56367902-56367911 |
3 | FAM48A | chr10:56365261-56365409 | GM12878 | blood: | n/a | n/a |
4 | GATA2 | chr10:56365914-56366691 | HUVEC | blood vessel: | n/a | n/a |
5 | GATA3 | chr10:56365251-56365446 | SH-SY5Y | brain: | n/a | n/a |
6 | GATA3 | chr10:56363804-56364057 | SH-SY5Y | brain: | n/a | n/a |
7 | GATA3 | chr10:56366654-56366782 | SH-SY5Y | brain: | n/a | n/a |
8 | GTF2F1 | chr10:56367699-56367761 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | MAFK | chr10:56363067-56363187 | HepG2 | liver: | n/a | n/a |
10 | NANOG | chr10:56367842-56368152 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | POLR2A | chr10:56367505-56367732 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | TAF7 | chr10:56367422-56367828 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | TBP | chr10:56367598-56367937 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | TCF12 | chr10:56367788-56368093 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | TCF12 | chr10:56367798-56368054 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | WRNIP1 | chr10:56365458-56365710 | GM12878 | blood: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MTRNR2L5-4 | chr10:56365452-56366745 | NONHSAT013457 |
2 | lnc-MTRNR2L5-4 | chr10:56365452-56366745 | ENSG00000234173.1 |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-548f-5p | chr10:56367686-56367707 | MIMAT0026739 |
hsa-miR-548f-3p | chr10:56367649-56367667 | MIMAT0005895 |
No data |
Variant related genes | Relation type |
---|---|
MIR548F1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558663443 | chr10:56364703-56364704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115550159 | chr10:56364722-56364723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561059586 | chr10:56364753-56364754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529719967 | chr10:56364802-56364803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538166713 | chr10:56364805-56364806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556521034 | chr10:56364850-56364851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7919891 | chr10:56364858-56364859 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs559674611 | chr10:56364879-56364880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532320115 | chr10:56364957-56364958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573604078 | chr10:56364971-56364972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552045269 | chr10:56364974-56364975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183639378 | chr10:56364989-56364990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531514478 | chr10:56365003-56365004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542638783 | chr10:56365006-56365007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548055030 | chr10:56365007-56365008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567765396 | chr10:56365021-56365022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7904980 | chr10:56365053-56365054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76812710 | chr10:56365069-56365070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566860689 | chr10:56365113-56365114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188682273 | chr10:56365116-56365117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs146525712 | chr10:56365118-56365119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575820114 | chr10:56365123-56365124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544805157 | chr10:56365160-56365161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192392530 | chr10:56365178-56365179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371391966 | chr10:56365202-56365203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78468683 | chr10:56365203-56365204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184980657 | chr10:56365268-56365269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188193338 | chr10:56365288-56365289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs75858916 | chr10:56365337-56365338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs79704786 | chr10:56365338-56365339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76809271 | chr10:56365379-56365380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1937412 | chr10:56365380-56365381 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs371230817 | chr10:56365525-56365526 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs571945832 | chr10:56365571-56365572 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs562826008 | chr10:56365579-56365580 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs568314029 | chr10:56365588-56365589 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs146993245 | chr10:56365589-56365590 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs201290302 | chr10:56365591-56365592 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs531474452 | chr10:56365598-56365599 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs548375751 | chr10:56365652-56365653 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs191551648 | chr10:56365690-56365691 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs184840918 | chr10:56365745-56365746 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs547097432 | chr10:56365768-56365769 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs116830246 | chr10:56365801-56365802 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs139108339 | chr10:56365803-56365804 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs375520150 | chr10:56365865-56365866 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs189779011 | chr10:56365887-56365888 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs114958154 | chr10:56365939-56365940 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs538108771 | chr10:56365945-56365946 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs555191448 | chr10:56365975-56365976 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56364600-56367600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr10:56365600-56366800 | Enhancers | HUVEC | blood vessel |
3 | chr10:56366800-56371200 | Weak transcription | HUVEC | blood vessel |
4 | chr10:56367000-56367800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr10:56367200-56368400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr10:56367600-56368000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr10:56367600-56368200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr10:56367600-56369200 | Enhancers | HUES64 Cell Line | embryonic stem cell |